Search Results - "Cancer and Oncology"

Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting

Saha, Sanjib, Gerdtham, Ulf-Göran, Sjödahl, Gottfrid, Häggström, Christel, Catto, James W. F., Kelly, John D., Ullén, Anders, Holmberg, Lars, Liedberg, Fredrik

Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Proactive Ageing, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Proaktivt åldrande, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Health Economics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Hälsoekonomi, Originator, Lund University, Lund University School of Economics and Management, LUSEM, Department of Economics, Lunds universitet, Ekonomihögskolan, Nationalekonomiska institutionen, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Urothelial cancer, Urothelial Cancer Genomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Urinblåsecancer, Genomiska analyser av urinblåscancer, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Urology - urothelial cancer, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Urologi - blåscancer, Malmö, Originator

The DNA methylation landscape of primary triple-negative breast cancer

Aine, Mattias, Nacer, Deborah F, Arbajian, Elsa, Veerla, Srinivas, Karlsson, Anna, Häkkinen, Jari, Johansson, Henrik J, Rosengren, Frida, Vallon-Christersson, Johan, Borg, Åke, Staaf, Johan

Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Breast/lung cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Bröst/lungcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/lungcancer, Research Group Lung Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/lungcancer, Forskningsgrupp Lungcancer, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, The genetics of soft tissue tumors, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Genetiska avvikelser i mjukdelstumörer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/ovarian cancer, Breast and Ovarian Cancer Genomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/ovarialcancer, Bröst- och ovarialcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, Familial Breast Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, Familjär bröstcancer, Originator

Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma

Kuras, Magdalena, Betancourt, Lazaro Hiram, Hong, Runyu, Szadai, Leticia, Rodriguez, Jimmy, Horvatovich, Peter, Pla, Indira, Eriksson, Jonatan, Szeitz, Beáta, Deszcz, Bartłomiej, Welinder, Charlotte, Sugihara, Yutaka, Ekedahl, Henrik, Baldetorp, Bo, Ingvar, Christian, Lundgren, Lotta, Lindberg, Henrik, Oskolas, Henriett, Horvath, Zsolt, Rezeli, Melinda, Gil, Jeovanis, Appelqvist, Roger, Kemény, Lajos V, Malm, Johan, Sanchez, Aniel, Szasz, Attila Marcell, Pawłowski, Krzysztof, Wieslander, Elisabet, Fenyö, David, Nemeth, Istvan Balazs, Marko-Varga, György

Lund University, Faculty of Medicine, Department of Translational Medicine, Clinical Chemistry, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Klinisk kemi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Mass Spectrometry, Clinical Protein Science and Imaging, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Masspektrometri, Clinical Protein Science and Imaging, Originator, Lund University, Faculty of Engineering, LTH, Departments at LTH, Department of Biomedical Engineering, Division for Biomedical Engineering, Lunds universitet, Lunds Tekniska Högskola, Institutioner vid LTH, Institutionen för biomedicinsk teknik, Avdelningen för biomedicinsk teknik, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Mass Spectrometry, BioMS, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Masspektrometri, BioMS, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Medical oncology, Lymphoma - Clinical Research, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Medicinsk onkologi, Lymfom - Klinisk forskning, Originator, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Light and Materials, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Ljus och material, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Surgery (Lund), Lund Melanoma Study Group, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Kirurgi, Lund, Lunds Melanomstudiegrupp, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Medical oncology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Medicinsk onkologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator

Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer: A Nationwide Population-based Study

Liedberg, Fredrik, Gårdmark, Truls, Hagberg, Oskar, Aljabery, Firas, Ströck, Viveka, Hosseini, Abolfazl, Malmström, Per Uno, Söderkvist, Karin, Ullén, Anders, Jerlström, Tomas, Jahnson, Staffan, Holmberg, Lars, Häggström, Christel

Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Urology - urothelial cancer, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Urologi - blåscancer, Malmö, Originator

Mapping Sentinel Vessels in Uveal Melanomas Using Laser Speckle Contrast Imaging

Engqvist, Linn, Dahlstrand, Ulf, Sheikh, Rafi, Malmsjö, Malin

Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Light and Materials, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Ljus och material, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section IV, Ophthalmology, Lund, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion IV, Oftalmologi, Lund, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Photon Science and Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Avancerade ljuskällor, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section IV, Ophthalmology, Lund, Ophthalmology Imaging Research Group, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion IV, Oftalmologi, Lund, Forskargruppen för oftalmologisk avbildning, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Thoracic Surgery, Clinical and experimental lung transplantation, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Thoraxkirurgi, Klinisk och experimentell lungtransplantation, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Thoracic Surgery, NPWT technology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Thoraxkirurgi, NPWT teknologin, Originator

Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma Microenvironment

Smolag-Klosowska, Karolina I, Olszowka, Jakub, Rosberg, Rebecca, Johansson, Elinn, Marinko, Elisabet, Leandersson, Karin, O'Connell, David J, Governa, Valeria, Tuysuz, Emre Can, Belting, Mattias, Pietras, Alexander, Martin, Myriam, Blom, Anna M

Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Brain Tumor Biology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Hjärntumörers biologi, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Protein Chemistry, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Proteinkemi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Family Medicine and Clinical Epidemiology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Allmänmedicin och klinisk epidemiologi, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Cancer Immunology, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Cancerimmunologi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Tumor microenvironment, Tumor microenvironment, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Tumörmikromiljö, Tumörmikromiljön, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Tumor microenvironment, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Tumörmikromiljö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Oncology corporate, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Onkologi övergripande, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EXODIAB: Excellence of Diabetes Research in Sweden, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EXODIAB: Excellence of Diabetes Research in Sweden, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Originator

Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes

Pla, Indira, Szabolcs, Botond L., Péter, Petra Nikolett, Ujfaludi, Zsuzsanna, Kim, Yonghyo, Horvatovich, Peter, Sanchez, Aniel, Pawlowski, Krzysztof, Wieslander, Elisabet, Kuras, Magdalena, Murillo, Jimmy Rodriguez, Guedes, Jéssica, Pál, Dorottya M.P., Ascsillán, Anna A., Betancourt, Lazaro Hiram, Németh, István Balázs, Gil, Jeovanis, de Almeida, Natália Pinto, Szeitz, Beáta, Szadai, Leticia, Doma, Viktória, Woldmar, Nicole, Bartha, Áron, Pahi, Zoltan, Pankotai, Tibor, Győrffy, Balázs, Szasz, A. Marcell, Domont, Gilberto, Nogueira, Fábio, Kwon, Ho Jeong, Appelqvist, Roger, Kárpáti, Sarolta, Fenyö, David, Malm, Johan, Marko-Varga, György, Kemény, Lajos V.

Lund University, Faculty of Medicine, Department of Translational Medicine, Clinical Chemistry, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Klinisk kemi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Mass Spectrometry, Clinical Protein Science and Imaging, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Masspektrometri, Clinical Protein Science and Imaging, Originator, Lund University, Faculty of Engineering, LTH, Departments at LTH, Department of Biomedical Engineering, Division for Biomedical Engineering, Lunds universitet, Lunds Tekniska Högskola, Institutioner vid LTH, Institutionen för biomedicinsk teknik, Avdelningen för biomedicinsk teknik, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Mass Spectrometry, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Masspektrometri, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator

Radiomics analysis of ultrasound images to discriminate between benign and malignant adnexal masses with solid morphology on ultrasound

Moro, F., Vagni, M., Tran, H. E., Bernardini, F., Mascilini, F., Ciccarone, F., Nero, C., Giannarelli, D., Boldrini, L., Fagotti, A., Scambia, G., Valentin, L., Testa, A. C.

Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Obstetric, Gynaecological and Prenatal Ultrasound Research, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Obstetrisk, gynekologisk och prenatal ultraljudsdiagnostik, Originator

Confirmatory Biopsy Outcomes in Patients with Grade Group 2 Prostate Cancer: Implications for Early Management

Leni, Riccardo, Vertosick, Emily A., Liso, Nicole, Akin, Oguz, Carlsson, Sigrid V., Montorsi, Francesco, Briganti, Alberto, Eastham, James A., Fine, Samson W., Vickers, Andrew J., Ehdaie, Behfar

Lund University, Faculty of Medicine, Department of Translational Medicine, Urological cancer, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Urologisk cancerforskning, Malmö, Originator

Genomic characterization of the HER2-enriched intrinsic molecular subtype in primary ER-positive HER2-negative breast cancer

Hohmann, Lennart, Sigurjonsdottir, Kristin, Campos, Ana Bosch, Nacer, Deborah F., Veerla, Srinivas, Rosengren, Frida, Reddy, Poojaswini Thimmaraya, Häkkinen, Jari, Nordborg, Nicklas, Vallon-Christersson, Johan, Memari, Yasin, Black, Daniella, Bowden, Ramsay, Davies, Helen R., Borg, Åke, Nik-Zainal, Serena, Staaf, Johan

Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/lungcancer, Research Group Lung Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/lungcancer, Forskningsgrupp Lungcancer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Breast/lung cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Bröst/lungcancer, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, Molecular therapeutics in breast cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, Molekylära behandlingsstrategier vid bröstcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/ovarian cancer, Breast and Ovarian Cancer Genomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/ovarialcancer, Bröst- och ovarialcancer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Molecular Hematology (DMH), Systems Immunology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för molekylär hematologi, Systemimmunologi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, Familial Breast Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, Familjär bröstcancer, Originator

Two-Step Acoustic Cell Separation Based on Cell Size and Acoustic Impedance─toward Isolation of Viable Circulating Tumor Cells

Magnusson, Cecilia, Rezayati Charan, Mahdi, Augustsson, Per

Lund University, Faculty of Medicine, Department of Translational Medicine, Clinical Chemistry, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Klinisk kemi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Mass Spectrometry, Acoustofluidics group, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Masspektrometri, Acoustofluidics group, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), NanoLund: Centre for Nanoscience, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), NanoLund: Centre for Nanoscience, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Engineering Health, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Teknik för hälsa, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Nanoscience and Semiconductor Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Nanovetenskap och halvledarteknologi, Originator, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Light and Materials, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Ljus och material, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Originator, Lund University, Faculty of Engineering, LTH, Departments at LTH, Department of Biomedical Engineering, Division for Biomedical Engineering, Lunds universitet, Lunds Tekniska Högskola, Institutioner vid LTH, Institutionen för biomedicinsk teknik, Avdelningen för biomedicinsk teknik, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Photon Science and Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Avancerade ljuskällor, Originator

Metabolic syndrome is associated with breast cancer mortality: A systematic review and meta-analysis

Harborg, Sixten, Larsen, Helene Borup, Elsgaard, Stine, Borgquist, Signe

Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer, Breast cancer prevention & intervention, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer, Bröstcancer - prevention & intervention, Originator

Determining the effect of frailty on survival in advanced ovarian cancer: study protocol for a prospective multicentre national cohort study (FOLERO)

Hunde, Daniel, Ekerstad, Niklas, Asp, Mihaela, Kannisto, Päivi, Wedin, Madelene, Palmquist, Charlotte, Dahm-Kähler, Pernila, Brandberg, Yvonne, Abraham-Nordling, Mirna, Ahlund, Kristina, Morlin, Vilhelm, Groes-Kofoed, Nina, Salehi, Sahar

Lund University, Faculty of Medicine, Faculty Office - BMC, The Education Office, Division of Course Administration for the Medical Programme, Teachers at the Medical Programme, Lunds universitet, Medicinska fakulteten, Kansli M, Utbildningsenheten, Avdelningen för läkarprogrammets kursadministration, Lärare vid läkarprogrammet, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Obstetrics and Gynaecology (Lund), Advanced ovarian cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Obstetrik och gynekologi, Lund, Avancerad ovarialcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Obstetrics and Gynaecology (Lund), Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Obstetrik och gynekologi, Lund, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator

Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study

Hernström, Veronica, Josefsson, Viktoria, Sartor, Hanna, Schmidt, David, Larsson, Anna Maria, Hofvind, Solveig, Andersson, Ingvar, Rosso, Aldana, Hagberg, Oskar, Lång, Kristina

Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Radiology Diagnostics, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Diagnostisk radiologi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast cancer treatment, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancerbehandling, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast cancer treatment, The Liquid Biopsy and Tumor Progression in Breast Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancerbehandling, The Liquid Biopsy och Tumörprogression i Bröstcancer, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Urology - urothelial cancer, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Urologi - blåscancer, Malmö, Originator, Lund University, Faculty of Science, Centre for Mathematical Sciences, Mathematical Statistics, Lunds universitet, Naturvetenskapliga fakulteten, Matematikcentrum, Matematisk statistik, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), eSSENCE: The e-Science Collaboration, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), eSSENCE: The e-Science Collaboration, Originator

High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density

Corvigno, Sara, Fernebro, Josefin, Karlsson, Josefin Severin, Mezheieusky, Artur, Martín-Bernabé, Alfonso, De La Fuente, Laura Martin, Westbom-Fremer, Sofia, Carlson, Joseph W., Klein, Christian, Kannisto, Paivi, Hedenfalk, Ingrid, Malander, Susanne, Östman, Arne, Dahlstrand, Hanna

Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/ovarian cancer, Breast and Ovarian Cancer Genomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/ovarialcancer, Bröst- och ovarialcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/ovarian cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/ovarialcancer, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Obstetrics and Gynaecology (Lund), Advanced ovarian cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Obstetrik och gynekologi, Lund, Avancerad ovarialcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Obstetrics and Gynaecology (Lund), Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Obstetrik och gynekologi, Lund, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Tumor microenvironment, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Tumörmikromiljö, Originator

pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post-Initiation of Androgen Deprivation Therapy

Bialas, Piotr, Kobayashi, Tamae, Hellsten, Rebecka, Krzyzanowska, Agnieszka, Persson, Margareta, Marginean, Felicia, Trudel, Dominique, Garraway, Isla P., Trock, Bruce J., Taimen, Pekka, Saad, Fred, Mirtti, Tuomas, Knudsen, Beatrice, De Marzo, Angelo M., Bjartell, Anders

Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Urological cancer, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Urologisk cancerforskning, Malmö, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Medical Molecular Biology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Medicinsk molekylärbiologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), eSSENCE: The e-Science Collaboration, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), eSSENCE: The e-Science Collaboration, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator

Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups

Hoffmann, Thomas J, Graff, Rebecca E, Madduri, Ravi K, Rodriguez, Alex A, Cario, Clinton L, Feng, Karen, Jiang, Yu, Wang, Anqi, Klein, Robert J, Pierce, Brandon L, Eggener, Scott, Tong, Lin, Blot, William, Long, Jirong, Goss, Louisa B, Darst, Burcu F, Rebbeck, Timothy, Lachance, Joseph, Andrews, Caroline, Adebiyi, Akindele O, Adusei, Ben, Aisuodionoe-Shadrach, Oseremen I, Fernandez, Pedro W, Jalloh, Mohamed, Janivara, Rohini, Chen, Wenlong C, Mensah, James E, Agalliu, Ilir, Berndt, Sonja I, Shelley, John P, Schaffer, Kerry, Machiela, Mitchell J, Freedman, Neal D, Huang, Wen-Yi, Li, Shengchao A, Goodman, Phyllis J, Till, Cathee, Thompson, Ian, Lilja, Hans, Ranatunga, Dilrini K, Presti, Joseph, Van Den Eeden, Stephen K, Chanock, Stephen J, Mosley, Jonathan D, Conti, David V, Haiman, Christopher A, Justice, Amy C, Kachuri, Linda, Witte, John S

Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Clinical Chemistry, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Klinisk kemi, Malmö, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator

A two-phase epigenome-wide four-way gene–smoking interaction study of overall survival for early-stage non-small cell lung cancer

Chen, Leyi, Wang, Xiang, Xie, Ning, Zhang, Zhongwen, Xu, Xiaowen, Xue, Maojie, Yang, Yuqing, Liu, Liya, Su, Li, Bjaanæs, Maria, Karlsson, Anna, Planck, Maria, Staaf, Johan, Helland, Åslaug, Esteller, Manel, Christiani, David C., Chen, Feng, Zhang, Ruyang

Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/lungcancer, Research Group Lung Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/lungcancer, Forskningsgrupp Lungcancer, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/lungcancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/lungcancer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Breast/lung cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Bröst/lungcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Respiratory Medicine, Allergology, and Palliative Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Lungmedicin, allergologi och palliativ medicin, Originator

Cancer cells impair monocyte-mediated T cell stimulation to evade immunity

Elewaut, Anais, Estivill, Guillem, Bayerl, Felix, Castillon, Leticia, Novatchkova, Maria, Pottendorfer, Elisabeth, Hoffmann-Haas, Lisa, Schönlein, Martin, Nguyen, Trung Viet, Lauss, Martin, Andreatta, Francesco, Vulin, Milica, Krecioch, Izabela, Bayerl, Jonas, Pedde, Anna Marie, Fabre, Naomi, Holstein, Felix, Cronin, Shona M., Rieser, Sarah, Laniti, Denarda Dangaj, Barras, David, Coukos, George, Quek, Camelia, Bai, Xinyu, Muñoz i Ordoño, Miquel, Wiesner, Thomas, Zuber, Johannes, Jönsson, Göran, Böttcher, Jan P., Vanharanta, Sakari, Obenauf, Anna C.

Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Melanoma, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Melanom, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Melanoma, Melanoma Genomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Melanom, Melanoma Genomics, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Surgery (Lund), Lund Melanoma Study Group, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Kirurgi, Lund, Lunds Melanomstudiegrupp, Originator

FHL2 expression by cancer-associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma

Kanzaki, Ryu, Reid, Steven, Bolivar, Paulina, Sjölund, Jonas, Staaf, Johan, Larsson, Sara, Shintani, Yasushi, Pietras, Kristian

Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Experimental oncology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Experimentell onkologi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/lungcancer, Research Group Lung Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/lungcancer, Forskningsgrupp Lungcancer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Breast/lung cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Bröst/lungcancer, Originator